Legendary newsman Dan Rather is returning to a screen near you.
He joined Cheddar CEO Jon Steinberg to speak about his new show, which recently premiered on The Young Turks’ YouTube channel.
“It felt like the most natural thing in the world to me, because the best newscast in the world isn’t worth a damn if somebody’s not watching,” Rather said of his partnership with The Young Turks.
The former “CBS Evening News” anchor says he was drawn to The Young Turks because of its ability to reach millennials and other young news consumers. As viewers increasingly abandon cable TV for streaming platforms, Rather said it was important for him to go digital to connect with that audience.
“That’s where the audience is...let’s try to reach that audience where they are,” Rather said of the digital space.
The half-hour program, called “The News w/ Dan Rather,” provides analysis and commentary. It airs Mondays at 5:30pm ET.
For the full interview, [click here](https://cheddar.com/videos/dan-rathers-move-to-digital-media).
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
